6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trialJoo‐Yong Hahn, Young Bin Song, Ju Hyeon Oh et al.|The Lancet|2018Cited by 372
Clinical impacts of inhibition of renin–angiotensin system in patients with acute ST-segment elevation myocardial infarction who underwent successful late percutaneous coronary interventionPark Hyukjin, Joo Young Yang, Young Joon Hong et al.|Journal of Cardiology|2016Cited by 13
The Impact of Vascular Access for In-Hospital Major Bleeding in Patients with Acute Coronary Syndrome at Moderate- to Very High-Bleeding RiskKeun Ho Park, Myung Ho Jeong, Youngkeun Ahn et al.|Journal of Korean Medical Science|2013Cited by 8
TCTAP A-001 Twelve-month Clinical Outcomes of Transradial Coronary Artery Intervention: Comparison of the Right and Left Radial Artery ApproachJi Young Park, Hee-Yeol Kim, Seung‐Woon Rha et al.|Journal of the American College of Cardiology|2014Cited by 0
TCTAP A-121 Transradial Versus Transfemoral Intervention in ST-segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention with Drug-eluting StentsSeung‐Woon Rha, Hee-Yeol Kim, Byoung Geol Choi et al.|Journal of the American College of Cardiology|2014Cited by 0